T. Andrew Lister
#123,992
Most Influential Person Now
T. Andrew Lister's AcademicInfluence.com Rankings
T. Andrew Listerengineering Degrees
Engineering
#4011
World Rank
#5164
Historical Rank
Biomedical Engineering
#224
World Rank
#231
Historical Rank

T. Andrew Listerphilosophy Degrees
Philosophy
#5733
World Rank
#8620
Historical Rank
Logic
#2956
World Rank
#4040
Historical Rank

Download Badge
Engineering Philosophy
T. Andrew Lister's Degrees
- PhD Biomedical Engineering University of California, Berkeley
- Doctorate Medicine University of California, San Francisco
Why Is T. Andrew Lister Influential?
(Suggest an Edit or Addition)T. Andrew Lister's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A predictive model for aggressive non-Hodgkin's lymphoma. (1993) (4400)
- Revised response criteria for malignant lymphoma. (2007) (4137)
- The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. (1999) (3234)
- Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. (1999) (3170)
- Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. (2014) (3134)
- Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. (2003) (2541)
- A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin's lymphoma: a report of the Non-Hodgkin's Lymphoma Classification Project (1997) (1664)
- Stromal gene signatures in large-B-cell lymphomas. (2008) (1611)
- Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. (1989) (1526)
- World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. (1999) (1331)
- Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas. (2001) (576)
- Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. (1994) (559)
- The human type‐C retrovirus, HTLV, in blacks from the Caribbean region, and relationship to adult T‐cell leukemia/lymphoma (1982) (546)
- Antisera to acute lymphoblastic leukemia cells. (1975) (490)
- European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma. (2000) (472)
- Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. (2000) (453)
- Follicular lymphoma: prognostic factors for response and survival. (1986) (439)
- The World Health Organization Classification of Hematological Malignancies Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997 (2000) (404)
- Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment (1994) (380)
- The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting--Airlie House, Virginia, November, 1997. (2000) (346)
- Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center. (1995) (341)
- Hematopoietic stem cells express multiple myeloid markers: implications for the origin and targeted therapy of acute myeloid leukemia. (2005) (340)
- Characterization of Cells with a High Aldehyde Dehydrogenase Activity from Cord Blood and Acute Myeloid Leukemia Samples (2005) (324)
- The prognostic value of Ki67 immunostaining in non‐Hodgkin's lymphoma (1988) (301)
- Mutation of CEBPA in familial acute myeloid leukemia. (2004) (298)
- Genome-wide single nucleotide polymorphism analysis reveals frequent partial uniparental disomy due to somatic recombination in acute myeloid leukemias. (2005) (291)
- Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. (2003) (281)
- Failure to preserve fertility in patients with Hodgkin's disease (2004) (255)
- AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML. (2006) (247)
- Use of leucocyte‐poor blood components and HLA‐matched‐platelet donors to prevent HLA alloimmunization (1986) (216)
- Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell support for lymphoid malignancies. (2000) (207)
- CORRELATION OF TRANSFERRIN RECEPTOR EXPRESSION WITH HISTOLOGICAL CLASS AND OUTCOME IN NON-HODGKIN LYMPHOMA (1983) (181)
- Mantle cell lymphoma: natural history defined in a serially biopsied population over a 20-year period. (1995) (179)
- Relative Importance of Immune and Non‐Immune Causes of Platelet Refractoriness (1994) (177)
- Centrocytic lymphoma: a distinct clinicopathologic and immunologic entity. A multiparameter study of 18 cases at diagnosis and relapse. (1983) (177)
- Immunotherapy for Acute Myelogenous Leukaemia (1973) (177)
- Second cancer risk after chemotherapy for Hodgkin's lymphoma: a collaborative British cohort study. (2011) (175)
- Central nervous system toxicity of interferon. (1983) (174)
- Histological transformation of non‐hodgkin's lymphoma. A prospective study (1979) (173)
- Meta-analysis to evaluate the role of interferon in follicular lymphoma. (2005) (171)
- Bortezomib therapy in patients with relapsed or refractory lymphoma: potential correlation of in vitro sensitivity and tumor necrosis factor alpha response with clinical activity. (2006) (170)
- Diagnosis of acute promyelocytic leukaemia by RT‐PCR: detection of PML‐RARA and RARA‐PML fusion transcripts (1992) (165)
- Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenström's macroglobulinemia, and mantle-cell lymphoma. (1999) (165)
- Terminal Transferase Enzyme Assay and Immunological Membrane Markers in the Diagnosis of Leukaemia: a Multiparameter Analysis of 300 Cases (1980) (154)
- Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological type. (1978) (154)
- The significance of circulating cells carrying t(14;18) in long remission from follicular lymphoma. (1991) (150)
- Emotional support for cancer patients: what do patients really want? (1996) (149)
- Lymphoma classification--the gap between biology and clinical management is closing. (1996) (148)
- Multicenter phase II trial of immunotherapy with the humanized anti-CD22 antibody, epratuzumab, in combination with rituximab, in refractory or recurrent non-Hodgkin's lymphoma. (2006) (147)
- Blast Crisis of Chronic Myeloid Leukaemia (CML): II. CELL SURFACE MARKER ANALYSIS OF ‘LYMPHOID’AND MYELOID CASES (1976) (146)
- MVPP chemotherapy regimen for advanced Hodgkin's disease (1978) (145)
- Frequency of the Bcl-2/IgH rearrangement in normal individuals: implications for the monitoring of disease in patients with follicular lymphoma. (2001) (144)
- Role of image-guided core-needle biopsy in the management of patients with lymphoma. (1996) (143)
- Effect of dose and schedule on pharmacokinetics of high-dose cytosine arabinoside in plasma and cerebrospinal fluid. (1983) (143)
- Relation of “lymphoid” phenotype and response to chemotherapy incorporating vincristine‐prednisolone in the acute phase of Ph1 positive leukemia (1979) (139)
- Gonadal function in Hodgkin's disease: long-term follow-up of chemotherapy. (1982) (137)
- Breast cancer risk after supradiaphragmatic radiotherapy for Hodgkin's lymphoma in England and Wales: a National Cohort Study. (2012) (131)
- High-dose therapy and autologous stem-cell support for chemosensitive transformed low-grade follicular non-Hodgkin's lymphoma: a case-matched study from the European Bone Marrow Transplant Registry. (2001) (130)
- Effect of age on the characteristics and clinical behavior of non-Hodgkin's lymphoma patients. The Non-Hodgkin's Lymphoma Classification Project. (1997) (130)
- Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment. (2001) (128)
- Treatment of Hodgkin lymphoma: a 50-year perspective. (2014) (127)
- Isolated follicular lymphoma cells are resistant to apoptosis and can be grown in vitro in the CD40/stromal cell system. (1993) (127)
- Prognosis of patients receiving intensive care for lifethreatening medical complications of haematological malignancy (1988) (126)
- Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for follicular lymphoma. (1994) (124)
- Expression of human T and B lymphocyte cell-surface markers on leukaemic cells. (1974) (122)
- Segmental uniparental disomy is a commonly acquired genetic event in relapsed acute myeloid leukemia. (2008) (122)
- Microdeletions are a general feature of adult and adolescent acute lymphoblastic leukemia: Unexpected similarities with pediatric disease (2008) (120)
- A novel K509I mutation of KIT identified in familial mastocytosis-in vitro and in vivo responsiveness to imatinib therapy. (2006) (119)
- Combination chemotherapy for acute lymphoblastic leukaemia in adults. (1978) (118)
- Mutations of CEBPA in acute myeloid leukemia FAB types M1 and M2 (2003) (117)
- A UK multicentre phase II study of rituximab (chimaeric anti‐CD20 monoclonal antibody) in patients with follicular lymphoma, with PCR monitoring of molecular response (2000) (115)
- Treatment of mantle-cell lymphoma with Rituximab (chimeric monoclonal anti-CD20 antibody): analysis of factors associated with response. (2000) (115)
- The proteasome inhibitor bortezomib acts independently of p53 and induces cell death via apoptosis and mitotic catastrophe in B-cell lymphoma cell lines. (2007) (111)
- A new member of the proprotein convertase gene family (LPC) is located at a chromosome translocation breakpoint in lymphomas. (1996) (105)
- FATAL GRAFT-VERSUS-HOST DISEASE FOLLOWING TRANSFUSION OF GRANULOCYTES FROM NORMAL DONORS (1976) (103)
- Tositumomab and iodine I 131 tositumomab for recurrent indolent and transformed B-cell non-Hodgkin's lymphoma. (2004) (101)
- Fludarabine phosphate for the treatment of low grade lymphoid malignancy. (1991) (100)
- Loss of CD20 expression following treatment with rituximab (chimaeric monoclonal anti‐CD20): a retrospective cohort analysis (2001) (99)
- Cisplatin combination chemotherapy versus chlorambucil in advanced ovarian carcinoma: mature results of a randomized trial. (1985) (97)
- Factors which predict unsuccessful mobilisation of peripheral blood progenitor cells following G-CSF alone in patients with non-Hodgkin's lymphoma. (2000) (97)
- Novel chimaeric protein expressed in Philadelphia positive acute lymphoblastic leukaemia (1987) (96)
- Detection of cells bearing the t(14;18) translocation following myeloablative treatment and autologous bone marrow transplantation for follicular lymphoma. (1994) (94)
- High-dose therapy with autologous haematopoietic support in patients with transformed follicular lymphoma: a study of 27 patients from a single centre. (1998) (90)
- Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient. (1977) (87)
- Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation. (2009) (85)
- Acute lymphoblastic leukaemia associated antigen. III ALterations in expression during treatment and in relapse. (1980) (85)
- Genome-wide detection of recurring sites of uniparental disomy in follicular and transformed follicular lymphoma (2007) (84)
- The use of real‐time quantitative polymerase chain reaction and comparative genomic hybridization to identify amplification of the REL gene in follicular lymphoma (2000) (84)
- ChlVPP/EVA hybrid versus the weekly VAPEC-B regimen for previously untreated Hodgkin's disease. (2002) (82)
- USE OF LEUCOCYTE‐POOR BLOOD COMPONENTS TO PREVENT PRIMARY CYTOMEGALOVIRUS (CMV) INFECTION IN PATIENTS WITH ACUTE LEUKAEMIA (1988) (79)
- Prevalence and clinical correlations of MLL gene rearrangements in AML-M4/5. (1994) (76)
- Treatment of acute lymphoblastic leukaemia in adults (1986) (76)
- Long term prognosis and quality of life following intensive care for life-threatening complications of haematological malignancy. (1991) (74)
- Asymptomatic carotid arterial disease in young patients following neck radiation therapy for Hodgkin lymphoma. (1999) (74)
- Immunotherapy for acute myelogenous leukemia. (1975) (74)
- Management of follicular lymphoma (1991) (72)
- Durable remissions of myelodysplastic syndrome and acute myeloid leukemia after reduced-intensity allografting. (2003) (71)
- Angio-immunoblastic lymphadenopathy: report of ten cases and review of the literature. (1979) (70)
- Pharmacokinetic study of single doses of oral fludarabine phosphate in patients with "low-grade" non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia. (1999) (69)
- Membrane phenotyping: diagnosis, monitoring and classification of acute 'lymphoid' leukaemias. (1977) (69)
- Characteristics of Sternberg-Reed, and related cells in Hodgkin's disease: an immunohistological study. (1984) (68)
- The pharmacokinetics of cytosine arabinoside in the plasma and cerebrospinal fluid during conventional and high-dose therapy. (1982) (66)
- Interferon-alpha 2b in the treatment of follicular lymphoma: preliminary results of a trial in progress. (1991) (65)
- Fludarabine in low-grade lymphoma. (1993) (65)
- Plasma cell leukemia (PCL): A report on 15 patients (1978) (61)
- Heterogeneous sensitivity of human Acute Myeloid Leukemia to ß-catenin down-modulation (2011) (60)
- Beta-2 microglobulin: a prognostic factor in diffuse aggressive non-Hodgkin's lymphomas. (1993) (59)
- The clinical course of follicular lymphoma. (2005) (57)
- Detection of chromosome abnormalities pre-high-dose treatment in patients developing therapy-related myelodysplasia and secondary acute myelogenous leukemia after treatment for non-Hodgkin's lymphoma. (2001) (55)
- 2'-Chlorodeoxyadenosine: evaluation of a novel predominantly lymphocyte selective agent in lymphoid malignancies. (1993) (54)
- A randomized controlled trial to evaluate the role of interferon as initial and maintenance therapy in patients with follicular lymphoma (2001) (53)
- Short-term treatment for acute myelogenous leukaemia. (1982) (52)
- Prognostic factors for survival in stage IIIB and IV Hodgkin's disease: a multivariate analysis comparing two specialist treatment centres. (1988) (52)
- Oral anticandidal prophylaxis in patients undergoing chemotherapy for acut- leukemia. (1977) (52)
- Nodular type of lymphocyte predominant Hodgkin's disease. A clinical study of 50 cases. (1995) (51)
- Lymphoma Metastasizing to the Pituitary: An Unusual Presentation of a Treatable Disease (2005) (50)
- Patterns of outcome following recurrence after myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma. (1999) (50)
- Incidence and outcome of critical illness amongst hospitalised patients with haematological malignancy: a prospective observational study of ward and intensive care unit based care * (2005) (49)
- Patterns of clinical presentation, treatment, and outcome in patients with Waldenstrom's macroglobulinemia: a two-institution study. (2003) (49)
- Abnormalities of chromosome 16q in myeloid malignancy: 14 new cases and a review of the literature. (1992) (49)
- Efficacy and safety of oral fludarabine phosphate in previously untreated patients with chronic lymphocytic leukemia. (2004) (49)
- Chromosome 11q23 translocations in both infant and adult acute leukemias are detected by in situ hybridization with a yeast artificial chromosome. (1992) (48)
- Management of localized non‐Hodgkin's lymphoma: The experience at St. Bartholomew's hospital 1972–1985 (1989) (48)
- Early involvement of the bronchi in patients with malignant lymphoma. (1983) (48)
- A phase II study to evaluate the combination of fludarabine, mitoxantrone and dexamethasone (FMD) in patients with follicular lymphoma. (2000) (48)
- Human T‐cell leukaemia virus (HTLV) in the United Kingdom (1984) (47)
- Long Term Follow-up of the PRIMA Study: Half of Patients Receiving Rituximab Maintenance Remain Progression Free at 10 Years (2017) (46)
- The management of recurrent acute myelogenous leukaemia at a single centre over a fifteen‐year period (1993) (46)
- Chlorambucil and interferon for low grade non-Hodgkin's lymphoma. (1987) (45)
- Disappearance of HLA and platelet‐specific antibodies in acute leukaemia patients alloimmunized by multiple transfusions (1987) (45)
- Hodgkin's disease in adults: the challenge. (1985) (45)
- Chemotherapy of the non‐Hodgkin's lymphomas (1978) (45)
- Renal involvement in patients with non‐Hodgkin's lymphoma: Clinical and pathological features in 23 cases (1990) (45)
- Detection and significance of bcr-abl mRNA transcripts and fusion proteins in Philadelphia-positive adult acute lymphoblastic leukemia. (1993) (43)
- Frequency of Leukemic Initiating Cells does not depend on the xenotransplantation model used (2011) (42)
- A Cross‐matching Procedure for the Selection of Platelet Donors for Alloimmunized Patients (1981) (42)
- Intensive therapy for life-threatening medical complications of haematological malignancy (2004) (42)
- A clinical and epidemiological study of human leukocyte antigen-DPB alleles in Hodgkin's disease. (1994) (41)
- Immunophenotype of blast cells in acute myeloid leukemia may be a useful predictive factor for outcome (1990) (39)
- Central nervous system toxicity of high-dose cytosine arabinoside. (1985) (39)
- Plasma cell leukemia (PCL): A report on 15 patients. (1978) (37)
- A Phase I Clinical Trial of CHT-25 a 131I-Labeled Chimeric Anti-CD25 Antibody Showing Efficacy in Patients with Refractory Lymphoma (2009) (37)
- The activity of methylated and non-methylated selenium species in lymphoma cell lines and primary tumours. (2006) (36)
- Direct sequence analysis of the t(14;18) chromosomal translocation in Hodgkin's disease. (1992) (35)
- Acute myeloid leukemia in elderly adults (1990) (35)
- The treatment of stage IIIA Hodgkin's disease. (1983) (34)
- Chemotherapy and immunotherapy for acute myelogenous leukemia (1980) (34)
- Distribution of T-lymphocyte subsets in Hodgkin's disease characterized by monoclonal antibodies. (1982) (34)
- Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors (2013) (34)
- Patterns of relapse and subsequent management following high-dose chemotherapy with autologous haematopoietic support in relapsed or refractory Hodgkin's lymphoma: a two centre study. (2000) (34)
- Lymphoplasmacytoid and small cell centrocytic non‐Hodgkin's lymphoma—A retrospective analysis from St Bartholomew's hospital 1972–1986 (1989) (33)
- HLA-DP BASED RESISTANCE TO HODGKIN'S DISEASE (1989) (33)
- p53 expression in Reed-Sternberg cells of Hodgkin's disease. (1992) (33)
- Detection of additional JH/BCL2 translocations in follicular lymphoma. (1991) (32)
- Translocation t(6;9)(p23;q34) in acute myeloid leukemia without myelodysplasia or basophilia: two cases and a review of the literature. (1993) (32)
- Immunocytoma: a retrospective analysis from St Bartholomew's Hospital-1972 to 1996. (1999) (31)
- Combination chemotherapy for haematological relapse in adult acute lymphoblastic leukaemia (ALL) (1978) (31)
- Tumour necrosis factor polymorphisms and susceptibility to follicular lymphoma (1999) (31)
- Life expectancy of young adults with follicular lymphoma. (2015) (31)
- APPARENT REMOVAL OF GRAFT‐VERSUS‐LEUKAEMIA EFFECT BY THE USE OF LEUCOCYTE‐POOR BLOOD COMPONENTS IN PATIENTS WITH ACUTE MYELOBLASTIC LEUKAEMIA (1989) (31)
- Secondary central nervous system lymphoma: risk factors and prophylaxis. (2005) (29)
- Low field strength magnetic resonance imaging of bone marrow in patients with malignant lymphoma. (1988) (29)
- The Cotswolds report on the investigation and staging of Hodgkin's disease. (1990) (28)
- The pharmacokinetics of subcutaneous cytosine arabinoside in patients with acute myelogenous leukaemia. (1981) (28)
- Adrenal enlargement and failure of suppression of circulating cortisol by dexamethasone in patients with malignancy (1999) (28)
- Angio-immunoblastic lymphadenopathy: a clinical, immunological and molecular study. (1987) (28)
- Peripheral T-cell lymphoma following rituximab therapy for B-cell lymphoma. (1999) (28)
- Acute lymphoblastic leukaemia in adults: clinicopathological correlations with the French-American-British (FAB) co-operative group classification. (1979) (28)
- Radiotherapy for stage I Hodgkin's disease: 20 years experience at St Bartholomew's Hospital. (1990) (27)
- NEW APPROACHES TO THE TREATMENT OF FOLLICULAR LYMPHOMA (1991) (27)
- Acute haemolysis after ABO-incompatible platelet transfusions (1990) (27)
- BCL2 protein expression in follicular lymphomas with t(14;18) chromosomal translocations (2009) (26)
- Use of the polymerase chain reaction and direct sequencing analysis to detect cells with the t(14;18) in autologous bone marrow from patients with follicular lymphoma, before and after in vitro treatment (1998) (26)
- Follicular non-Hodgkin's lymphoma. (1987) (25)
- Localisation of a novel region of recurrent amplification in follicular lymphoma to an approximately 6.8 Mb region of 13q32-33. (2001) (25)
- Staging for Hodgkin's disease. (1979) (25)
- Early central nervous system involvement in adults with acute non-myelogenous leukaemia. (1977) (24)
- Localized non-Hodgkin's Lymphoma. (1980) (24)
- The management of localized, infradiaphragmatic Hodgkin's disease: Experience of a rare clinical presentation at St Bartholomew's Hospital (1984) (24)
- The air crescent sign of invasive pulmonary aspergillosis in acute leukaemia. (1982) (24)
- The treatment of acute myelogenous leukemia in adults. (1982) (24)
- Treatment of acute myelogenous leukemia. (1997) (24)
- Human trithorax gene rearrangements in therapy-related acute leukaemia after etoposide treatment. (1994) (23)
- Mediastinal large-cell lymphoma with sclerosis (MLCLS). (1994) (23)
- Prophylactic granulocyte transfusions: results of a randomized controlled trial in patients with acute myelogenous leukemia (1982) (22)
- Computed tomography (CT) and ultrasound (US) guided core biopsy in the management of non-Hodgkin's lymphoma. (1991) (22)
- Mutation of BRAF is uncommon in AML FAB type M1 and M2 (2003) (22)
- Interferon alfa-2b in addition to chlorambucil in the treatment of follicular lymphoma: preliminary results of a randomized trial in progress. (1991) (22)
- Overexpression of wild-type or mutants forms of CEBPA alter normal human hematopoiesis (2012) (22)
- Weekly VAPEC-B chemotherapy for high grade non-Hodgkin's lymphoma: results of treatment in 184 patients. (1994) (22)
- Immunocytochemical demonstration of PTHrP protein in neoplastic tissue of HTLV-1 positive human adult T cell leukaemia/lymphoma: implications for the mechanism of hypercalcaemia. (1991) (22)
- Staging in Hodgkin's disease. (1979) (21)
- The t(14;18) chromosomal translocation and Bcl-2 protein expression in Hodgkin's disease. (1994) (21)
- Detection of spread of malignant lymphoma to the liver by low field strength magnetic resonance imaging. (1986) (21)
- Hepatitis C infection in multitransfused patients with acute leukaemia (1990) (20)
- Gonadal function in men treated for acute leukaemia. (1983) (20)
- CT appearances of mucosa-associated lymphoid tissue (MALT) lymphoma (1999) (19)
- Primary gastrointestinal non-Hodgkin lymphoma: still an unresolved question? (1993) (19)
- Fluorescence in situ hybridisation studies to characterise complete and partial monosomy 7 in myeloid disorders (1994) (19)
- HODGKIN'S DISEASE OCCURRING DURING ACUTE LEUKÆMIA IN REMISSION (1977) (19)
- Duplication of one of the products of the t(8;21) translocation in a patient with refractory anemia with excess blasts in transformation. (1987) (19)
- Burkitt's lymphoma in British adults: clinical features and response to chemotherapy. (1977) (19)
- Low field strength magnetic resonance imaging of bone marrow in acute leukaemia (1988) (19)
- The management of stage II supradiaphragmatic Hodgkin's disease at St. Bartholomew's hospital: A retrospective review of 114 previously untreated patients over 14 years (1984) (19)
- A phase I study of human lymphoblastoid interferon administered by continuous intravenous infusion (2004) (18)
- Phase II Clinical Study of Bortezomib (VELCADE®) in Patients (pts) with Relapsed / Refractory Non-Hodgkin’s Lymphoma (NHL) and Hodgkin’s Disease (HD). (2004) (18)
- The management of chronic lymphocytic leukemia at a single centre over a 24‐year period: prognostic factors for survival (1994) (18)
- Acute myelogenous leukemia (AML) and diabetes insipidus (DI): Further association with monosomy 7 (1992) (18)
- Long‐term outcome of patients surviving for more than ten years following treatment for acute leukaemia (2001) (17)
- ALL masquerading as AUL. (1983) (17)
- Superior outcomes associated with earlier use: Experience with tositumomab and iodine I 131 tositumomab in 1,177 patients (pts) with low-grade, follicular, and transformed non-Hodgkin’s lymphoma (NHL) (2005) (17)
- Role of early anthracycline dose-intensity according to expression of Philadelphia chromosome/BCR-ABL rearrangements in B-precursor adult acute lymphoblastic leukemia. (2000) (17)
- Association of HLA-DPB with Hodgkin's disease (1992) (17)
- Treatment of low grade non-Hodgkin's lymphomas with fludarabine. (1993) (17)
- AML1/ETO proteins control POU4F1/BRN3A expression and function in t(8;21) acute myeloid leukemia. (2010) (16)
- The role of computed tomography in the detection of intrathoracic lymphoma. (1984) (16)
- Safe Method of Collecting Leukaemia Cells from Patients with Acute Leukaemia for Use as Immunotherapy (1974) (16)
- Serum LDH, a prognostic factor in elderly patients with acute myelogenous leukaemia (2001) (15)
- Molecular characterization of a new recombination of the SIL/TAL‐1 locus in a child with T‐cell acute lymphoblastic leukaemia (2002) (15)
- Second primary malignant neoplasms in patients treated for hodgkin's disease at st bartholomew's hospital (1986) (15)
- The management of stage 111a hodgkin's disease (1980) (15)
- Improved survival for patients with follicular lymphoma. (2005) (15)
- E-SHAP: inadequate treatment for poor-prognosis recurrent lymphoma. (1993) (14)
- The t(14;18) in a patient with de novo acute lymphoblastic leukemia is associated with t(8;9). (1994) (14)
- Oral idarubicin in the treatment of acute myelogenous leukaemia and the blast phase of chronic myeloid leukaemia (1989) (14)
- High-dose cytosine arabinoside: response to therapy in acute leukaemia and non-Hodgkin's lymphoma (2004) (14)
- Genetic susceptibility to Hodgkin's disease and secondary neoplasias: FISH analysis reveals patients at high risk of developing secondary neoplasia. (2002) (14)
- Simultaneous presentation of T- and B-cell malignant lymphoma with bcl- 2 gene involvement (1989) (13)
- HLA CLASS I AND CLASS II ANTIGEN ASSOCIATIONS IN ACUTE LEUKAEMIAS (1986) (13)
- The treatment of acute myelogenous leukemia. (1987) (12)
- Molecular cloning of a novel 11q23 breakpoint associated with non-Hodgkin's lymphoma. (1994) (12)
- Minimal residual disease in leukaemia and lymphoma. (1990) (12)
- EVA treatment for recurrent or unresponsive Hodgkin's disease (2004) (12)
- The treatment of postmenopausal women with advanced breast cancer with buserelin (2004) (12)
- Incidence of the 15q+;17q- chromosome translocation in acute promyelocytic leukaemia (APL). (1985) (12)
- Posttreatment laparotomy as a guide to management in patients with Hodgkin's disease. (1982) (12)
- High-dose treatment with autologous bone marrow support as consolidation of first remission in younger patients with acute myelogenous leukaemia. (2000) (12)
- Current management of follicular lymphoma. (1996) (12)
- Induction of CD80 expression in low-grade B cell lymphoma--a potential immunotherapeutic target. (1995) (12)
- High-dose cytosine arabinoside in the initial treatment of acute leukemia. (1985) (12)
- Preliminary results of a phase I/II study of weekly or twice weekly bortezomib in combination with rituximab, in patients with follicular lymphoma, mantle cell lymphoma and Waldenström's macroglobulinaemia (2007) (12)
- Development of response criteria (rc) for low-grade or follicular lymphomas (lg/f nhl) and application in a 166 patient study (1997) (12)
- Neurological illness following treatment with fludarabine. (1994) (11)
- The use of high-dose cytosine arabinoside for non-Hodgkin's lymphoma. (1985) (11)
- Meningeal leukaemia in lymphoid blast crisis of chronic myeloid leukaemia. (1977) (11)
- Neurotoxicity of high-dose cytosine arabinoside. (1985) (11)
- Myeloablative therapy for follicular lymphoma. (1991) (11)
- Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy (2000) (11)
- Proliferation of Reed-Sternberg cells and variants in Hodgkin's disease. (1994) (11)
- A comparison of two schedules of cytosine arabinoside used in combination with adriamycin and 6-thioguanine in the treatment of acute myelogenous leukemia. (1982) (11)
- Prognostic importance of immunologic markers in adult acute lymphoblastic leukemia. (1981) (11)
- Combined granulocyte and platelet transfusions. Development of alloimmunization as reflected by decreasing cell recovery values (1982) (11)
- Intensive chemotherapy for adult acute lymphoblastic leukaemia given with or without granulocyte-macrophage colony stimulating factor (1996) (10)
- Chronic lymphocytic leukaemia presenting as a blast cell crisis. (1984) (10)
- Should high-dose chemotherapy be used to consolidate second or third line treatment in relapsing germ cell tumours? (2000) (10)
- PCR Analysis for the t(14;18) Translocation in Patients With Recurrent Follicular Lymphoma Following Immunotherapy With Rituximab (IDEC-C2B8) (1999) (9)
- Mitoxantrone and cytosine arabinoside as treatment for acute myeloblastic leukemia in older patients (1995) (9)
- Relationship between Protein Binding and Extravascular drug Concentrations of a Water-soluble Drug, Cytosine Arabinoside 1 (1983) (9)
- The Activity of the Novel Aurora Kinase B Inhibitor AZD1152 in Acute Myeloid Leukaemia Cells. (2005) (9)
- Autoimmune thrombocytopenia and neutropenia after remission induction therapy for acute leukaemia (1986) (9)
- Possible prolongation of remission in acute myeloid leukemia by granulocyte transfusions. (1980) (9)
- Central nervous system toxicity of interferon. (1985) (9)
- Limited activity of ICRF-159 in advanced acute leukemia. (1979) (9)
- Prognostic factors in lymphoma (1987) (9)
- Role of additional radiotherapy in advanced stages of Hodgkin's disease. (1992) (8)
- 15/17 chromosome translocation in acute promyelocytic leukemia. (1982) (8)
- High-dose therapy for follicular lymphoma revisited: not if, but when? (2003) (8)
- A phase I and II study of m-AMSA in acute leukaemia (2004) (8)
- The effect of cytokines on cultured mononuclear cells from patients with B cell chronic lymphocytic leukemia (1993) (7)
- Experience with human lymphoblastoid interferon in acute myelogenous leukaemia (AML) (2004) (7)
- THE CHALLENGE OF ACIJTE LYMPHOBLASTIC LEIIKAEMIA IN ADULTS (1993) (7)
- Mutation of CEBPA in Familial Acute Myeloid Leukaemia. (2004) (7)
- Who should receive myeloablative therapy for lymphoma? (2004) (7)
- Subtle abnormalities in the short arm of chromosome 11 in acute myeloid leukemia. (1987) (7)
- Etoposide in combination with intermediate dose cytosine arabinoside (ID ARA C) given with the intention of further myeloablative therapy for the treatment of refractory or recurrent hematological malignancy (1992) (7)
- Prognostic significance of cell surface phenotype in adult acute lymphoblastic leukaemia (1979) (7)
- Low-dose continuous chemotherapy (LBCMVD-56) for refractory and relapsing lymphoma. (2000) (7)
- The management of follicular lymphoma. (1994) (7)
- Interim results of a UK NCRI randomised trial comparing involved field radiotherapy with no further treatment after 3 cycles ABVD and a negative PET scan in clinical stages IA/IIA Hodgkin lymphoma (2007) (7)
- In vitro testing of calcium channel blockers and cytotoxic chemotherapy in B-cell low-grade non-Hodgkin's lymphoma. (1998) (6)
- Polyradiculopathy complicating acute lymphoblastic leukemia (1995) (6)
- Assignment1 of brain acid-soluble protein 1 (BASP1) to human chromosome 5p15.1→p14, differential expression in human cancer cell lines as a result of alterations in gene dosage (2000) (6)
- The role of transtracheal aspiration in the diagnosis of respiratory infection in neutropenic patients with acute leukaemia. (1981) (6)
- Subcutaneous infusion of cytosine arabinoside (1983) (6)
- Sclerosing B-cell lymphoma of the mediastinum: entity or non-entity? (1991) (6)
- Iodine-131 Tositumomab For Patients With Small Lymphocytic Lymphoma (SLL): Overall Clinical Trial Experience (2000) (6)
- Simultaneous presentation of T- and B-cell malignant lymphoma with bcl-2 gene involvement. (1989) (6)
- POLYMERASE CHAIN REACTION TO CONFIRM EXTRANODAL PROGRESSION OF FOLLICULAR LYMPHOMA (1989) (6)
- Primary gastric non-Hodgkin's lymphoma: a therapeutic challenge. (1993) (6)
- William Dameshek and Frederick Gunz's Leukemia (1990) (6)
- Opec chemotherapy (vincristine, prednisolone, etoposide and chlorambucil) for refractory and recurrent Hodgkin's disease (1987) (6)
- The treatment of stage IIIA Hodgkin's disease--total nodal irradiation versus combination chemotherapy: either or neither. (1991) (6)
- Application of Jackson, Aspden Acute Myeloid Leukaemia Model (1982) (6)
- Oral idarubicin as a palliative agent in leukemia (2006) (6)
- Low field strength magnetic resonance imaging of the spleen: results from volunteers and patients with lymphoma. (1988) (6)
- The pharmacokinetics of subcutaneous bolus cytosine arabinoside in an arachis oil plus aluminium distearate suspension (2004) (5)
- The clinical pharmacology of cytosine arabinoside. (1983) (5)
- Assignment1 of B-cell lymphoma 6, member B (zinc finger protein) gene (BCL6B) to human chromosome 17p13.1 by in situ hybridization (2000) (5)
- Waldenstrom's macroglobulinemia: a retrospective analysis of 40 patients from 1972 to 2001. (2003) (5)
- Conventional dose cytosine arabinoside in combination chemotherapy for acute myelogenous leukemia. (1987) (5)
- Recombinant interferon‐ALPHA2b and high dose methyl prednisolone in relapsed and resistant multiple myeloma (1993) (5)
- Prognostic factors in adult acute lymphoblastic leukemia. (1979) (5)
- T‐cell replete fludarabine/cyclophosphamide reduced intensity allogeneic stem cell transplantation for lymphoid malignancies (2012) (5)
- Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues : Report of the Clinical Advisory Committee Meeting — Airlie House , Virginia , November 1997 By (1999) (5)
- SURVIVAL IN ACUTE MYELOID LEUKÆMIA (1975) (5)
- Blood component therapy. (1978) (5)
- Cytosine arabinoside in the management of recurrent leukaemia (1987) (5)
- Treatment of acute leukaemia with m-AMSA in combination with cytosine arabinoside (2004) (5)
- Treatment of acute nonlymphocytic leukemia with neocarzinostatin. (1979) (5)
- Tositumomab and I 131 Tositumomab Achieves Complete Remissions Lasting > 10 Years In Patients with Chemotherapy-Refractory Low-Grade and Transformed B-Cell Lymphomas (2010) (5)
- Hairy cell leukemia—mediastinal involvement. A report of two cases and review of the literature (1989) (4)
- Infection in acute myelogenous leukaemia. An analysis of 168 patients undergoing remission induction. (1981) (4)
- Tositumomab and Iodine I 131 Tositumomab (The BEXXAR® Therapeutic Regimen) Produced Ongoing, Durable Remissions of More Than 5 Years in 9 Patients with Non-Hodgkin’s Lymphoma (NHL) in a Pivotal Study of Patients Refractory to Their Last Chemotherapy. (2004) (4)
- Clinical sensitivity to anthracyclines in PH/BCR+ acute lymphoblastic leukemia. (1999) (4)
- Patterns of CNS Involvement in Malignant Lymphoma (1979) (4)
- Myeloablative therapy with autologous bone marrow transplantation (ABMT) as consolidation of first remission in younger patients with acute myelogenous leukaemia (AML). (1993) (4)
- A phase I study of human lymphoblastoid interferon in patients with hematological malignancies. (1981) (4)
- Small-cell lung carcinoma: survival after combination chemotherapy, radiotherapy or symptomatic treatment. (1983) (4)
- Treatment of refractory splenomegaly in myeloproliferative disease by splenic artery infusion. (1979) (4)
- Lack of prognostic value of the thymidine-labelling index in adult acute leukaemia. (1981) (4)
- Lymphdx: A Custom Microarray for Molecular Diagnosis and Prognosis in Non-Hodgkin Lymphoma. (2004) (4)
- Recombinant human granulocyte macrophage colony stimulating factor following alternating non cross resistant chemotherapy in hodgkin's disease (2006) (4)
- Multi-centre, phase II study of combination antibody therapy with epratuzumab plus rituximab in relapsed/refractory indolent and aggressive NHL: Promising preliminary results (2004) (4)
- Assessment of bone marrow infiltration in B-cell non-Hodgkin's lymphoma (NHL). (1989) (4)
- The challenge of acute lymphoblastic leukaemia in adults. (1993) (3)
- Interferon in acute myelogenous leukaemia: a preliminary report. (1983) (3)
- Malignant lymphoma of the ureter. (1985) (3)
- Progress in acute myeologenous leukemia. (1981) (3)
- Genome-Wide Micro-Deletions and Amplifications Acquired at Relapse in Acute Myeloid Leukemia. (2009) (3)
- Combination chemotherapy for advanced non-Hodgkin's lymphoma of unfavourable histology (2004) (3)
- The isolation of a yeast artificial chromosome which spans the chromosome 11q23 region involved in a number of translocations in acute leukaemias. (1993) (3)
- Reply to B. Bennani-Baiti et al, H.J.A. Adams et al, E. Laffon et al, and E.A. Hawkes et al. (2015) (3)
- Short-term therapy for acute myelogenous leukaemia (AML) (1986) (3)
- The Follicular Lymphoma International Prognostic Index (FLIPI) Can Be a Useful Prognostic Indicator for Patients with Follicular Lymphoma Treated with Combination of Rituximab and Epratuzumab. (2005) (3)
- The proposed revised European-American classification of lymphoma. (1995) (3)
- Effect of ceftazidime and gentamicin on the oropharyngeal and faecal flora of patients with haematological malignancies. (1990) (3)
- Mantle Cell and Follicular Lymphoma Samples Demonstrate Differing Sensitivity to Bortezomib in a Primary Culture System. (2004) (3)
- Combined granulocyte and platelet transfusions: inter-relationship between granulocyte and platelet recoveries in the presence and absence of complicating factors. (2009) (3)
- Staging for hodgkins-disease. (1990) (3)
- THE STAGING AND TREATMENT OF NON‐HODGKIN'S LYMPHOMA (1978) (3)
- WHO SHOULD TREAT CANCER? (1981) (3)
- Follicular lymphoma: grounds for optimism. (1997) (3)
- Detection of somatic mutations of the bcl-2 oncogene in B cell lymphomas with the t(14;18). (1997) (2)
- Treatment of minimal residual disease in poor risk acute lymphoblastic leukaemia with high-dose cytosine arabinoside (ARA-C) (1986) (2)
- Late complications of cytotoxic chemotherapy given for advanced Hodgkin’s disease (1985) (2)
- Acute Myelogenous Leukaemia in Patients 60 Years and Older: A Retrospective Analysis from St Bartholomew's Hospital 1969–1999 (2001) (2)
- Genome Wide SNP Analysis Reveals Frequent Uniparental Disomy (UPD) Due to Somatic Recombination in Acute Myeloid Leukemias. (2004) (2)
- Multi-centre, phase II study of combination antibody therapy with epratuzumab plus rituximab in relapsed/refractory indolent and aggressive NHL: Promising preliminary results. (2004) (2)
- Phase II study of a high-dose regimen of cyclophosphamide and prednisolone in advanced non-Hodgkin's lymphoma of favorable histologic type. (1982) (2)
- p53 protein expression in Reed-Sternberg cells of Hodgkin's disease. (1993) (2)
- Can the polymerase chain reaction be used to direct therapy? (1993) (2)
- Management of stage II Hodgkin's disease: 15 years experience at St. Bartholomew's Hospital. (1992) (2)
- Chemotherapy of Hodgkin's disease. (1991) (2)
- Molecular Diagnosis of Lymphoma (2005) (2)
- Role of anthracycline dose intensity in adult Philadelphia chromosome/BCR-ABL positive and negative B-lineage acute lymphoblastic leukemia (1999) (2)
- Comparison of Clinical Trials in Acute Myelogenous Leukaemia by use of a Mathematical Model (1980) (2)
- The ‘tumour overkill syndrome’. A potentially lethal complication of cancer chemotherapy (1981) (2)
- Management of non-Hodgkin lymphoma in adults in Scandinavia, United Kingdom, and The Netherlands. Report from the European School of Oncology intercity meeting at Huddinge Hospital, 3rd June, 1988. (1989) (2)
- Treatment of Stage IIIa Hodgkin's disease: long follow-up perspective. (2008) (2)
- A phase II study of high-dose cytosine arabinoside in the treatment of acute leukaemia in adults (2004) (2)
- The lymphomas--current management. (1983) (2)
- Hodgkin's disease occurring during acute leukaemia in remission. (1977) (2)
- VAPEC B: a weekly chemotherapy for high grade non-Hodgkin's lymphoma. Early results of a collaborative trial at two centres. (1990) (1)
- Enteropathy-Type T-Cell Lymphoma: Clinical Features of a Series of 62 Cases. Jan Delabie, Harald Holte, Andrew Lister and Julie Vose for the International T-Cell Lymphoma Project. (2006) (1)
- The Relationship of Cell Morphology to CNS Involvement in Adult Leukaemia and Lymphoma (1979) (1)
- Patterns of relapse and subsequent management following high dose chemotherapy with autologous haemopoietic support in relapsed or refractory Hodgkin's lymphoma (2000) (1)
- Limited Success with a Postremission Strategy Comprising Conventional Consolidation and High-Dose Treatment (HDT) with Autologous Peripheral Progenitor Cell (PBPC) Support for Adult Acute Lymphoblastic Leukaemia (ALL) (2003) (1)
- Evaluation of emotional support for cancer patients (1997) (1)
- Acute promyelocytic leukaemia: a retrospective analysis of patients treated at St. Bartholomew's Hospital 1969–1995 (1999) (1)
- The management of stage IIIA Hodgkin's disease. (1980) (1)
- High-dose therapy with autologous haematopoietic support in patients with transformed follicular lymphoma: A study (2005) (1)
- Chronic Lymphocytic Leukemia (2003) (1)
- The treatment of disseminated non-Hodgkin's lymphoma of unfavourable histology (2004) (1)
- Generation of cytotoxic T lymphocytes from peripheral blood of leukaemic patients (2005) (1)
- Treatment of recurrent acute myelogenous leukaemia at a single centre over a 10-year period. (1990) (1)
- Acute myelogenous leukemia with dup(1)(p22p36),dup(1)(p22p36): a novel case? (1996) (1)
- Triple drug therapy of Herpes zoster infection occurring in patients with reticulo-endothelial neoplasia--a preliminary study. (1980) (1)
- Pivotal S tudy o f I odine I 1 31 T ositumomab f or Chemotherapy-Ref ractory L ow-Grade o r T ransformed Low-Grade B -Cell N on-Hodgkin's L ymphomas (2001) (0)
- Chronic lymphocytic leukaemia. (1991) (0)
- splenic artery infusion Treatment of refractory splenomegaly in myeloproliferative disease by (2012) (0)
- The Wiskott-Aldrich-Syndrome family member 1 (WASF1) gene on 6q21 is down-regulated in specific AML cytogenetic subtypes. (2003) (0)
- 772 Multicentre retrospective review of primary cutaneous lymphoma excluding mycosis fungoides (1995) (0)
- Levels of Evidence of Carcinogenicity (1993) (0)
- CT guided biopsy in the management of non-Hodgkin's lymphoma. (1990) (0)
- Presenting features of lymphoid neoplasms : S MONTOTO AND TA LISTER (2010) (0)
- Outcome of Patients with Refractory/Recurrent Acute Myelogenous Leukaemia (AML) Treated at a Single Centre (2003) (0)
- Historical prospect for the concept of primary extranodal lymphoma (2008) (0)
- Lowfield strength magnetic resonanceimaging ofthespleen: results from volunteers andpatients withlymphoma (1988) (0)
- Simultaneous presentation of B- and T-cell malignant lymphoma. (1989) (0)
- Monoclonal Antibodies for Cancer Detection (1986) (0)
- Resistance to Cytosine Arabinoside: Are Mutations in CTP Synthetase an Important Mechanism? (1994) (0)
- The management of generalised lymphoma. (1975) (0)
- Third Annual Meeting of the Association of Cancer Physicians (in Conjunction with the 29th Annual General Meeting of the British Association for Cancer Research)* (1988) (0)
- Gene Expression Model of Survival and Transformation in Follicular Lymphoma (FL): A Study by the LLMPP. (2007) (0)
- The Management of Follicular Lymphoma (2012) (0)
- Outcome after high-dose therapy with autologous stem cell rescue with BEAM for relapsed follicular lymphoma. (2011) (0)
- relapsed acute myeloid leukemia Segmental uniparental disomy is a commonly acquired genetic event in (2013) (0)
- Contents Vol. 89, 2000 (2000) (0)
- H.I.V. antibody testing in lymphoma patients. (1987) (0)
- Genome-Wide 500K SNP Array Analyses Reveal High Frequencies of Cryptic Genetic Abnormalities and Identify Recurrent Microdeletions Targeting Novel Genes in Adult Acute Lymphoblastic Leukemia. (2007) (0)
- Early Application of Anthracyclines in Adult Acute Lymphoblastic Leukemia (ALL) (2001) (0)
- Short-term therapy for acute myelogenous leukaemia in younger patients. (1983) (0)
- Response to Fludarabine in Patients with Low Grade Lymphoma (1996) (0)
- DNA sequence determination of CTP synthetase mutations in ara C-resistant hamster cells. (1991) (0)
- In vitro treatment of bone marrow from patients with T-cell acute lymphoblastic leukemia and non-Hodgkin's lymphoma using the immunotoxin WT1-ricin A. (1987) (0)
- Treatment of Disseminated Malignant Lymphoma (1984) (0)
- 17 Fluorodeoxyglucose (FDG) positron emission tomography (PET) in Lymphoma (2010) (0)
- Myelo-ablative therapy with ABMT for low grade non-Hodgkin's lymphoma (1995) (0)
- Diagnosis and management of pulmonary aspergillosis in patients with acute leukaemia (1980) (0)
- Letter: Survival in acute myeloid leukaemia. (1975) (0)
- The feasibility of opal/high dose Ara-C treatment of adult acute lymphoblastic leukaemia. (1985) (0)
- The role of image-guided biopsy in the management of patients with lymphoma (1996) (0)
- IN13 Follicular lymphoma (2012) (0)
- Management of elderly patients with 'aggressive' non-hodgkin's lymphoma (NHL) presenting to a single centre over three decades (2002) (0)
- Letter to the editor (1987) (0)
- Fludarabine in chronic lymphocytic leukaemia and non-Hodgkin's lymphoma. 5th Annual Meeting, Association of Cancer Physicians, March 1990. (1990) (0)
- Intensive combination chemotherapy for diffuse low grade non-Hodgkin's lymphomas of B- and T-cell lineage. (1993) (0)
- Subject Index Vol. 89, 2000 (2000) (0)
- THE ROLE OF COMPUTER TOMOGRAPHY IN THE DETECTION OF INTRATHORACIC LYMPHOMA (1985) (0)
- Combination chemotherapy foracutelymphoblastic leukaemia inadults (1978) (0)
- REVIEWARTICLES Thelymphomas-current management (1983) (0)
- Association of MicroRNA Expression Profiles with Karyotype in Acute Myeloid Leukaemias Revealed by Real-Time PCR and In Situ Hybridisation. (2007) (0)
- Diagnosis and staging or Hodgkin s disease (1990) (0)
- High-Dose Cytosine Arabinoside in the Treatment of Acute Lymphoblastic Leukaemia (1994) (0)
- Intermediate dose cytosine arabinoside and etoposide for the treatment of refractory or relapsed acute leukaemia and non-Hodgkin's lymphoma. (1991) (0)
- Clinical interferon (IFN) studies in leukemia and lymphoma (1985) (0)
- AML 1 / ETO Proteins Control POU 4 F 1 / BRN 3 A Expression and Function in t ( 8 ; 21 ) Acute Myeloid Leukemia (2010) (0)
- ‘ ‘ focus on . . . ’ ’ session : transformation 086 SNP ARRAY GENOTYPING IN 182 DIAGNOSTIC FOLLICULAR LYMPHOMA CASES IDENTIFIES SITES OF AUPD ASSOCIATED WITH OVERALL SURVIVAL AND RISK OF TRANSFORMATION (2008) (0)
- Development of a Human Acute Myeloid Leukaemia Screening Panel and Identification of Novel Gene Mutations. (2004) (0)
- Cytosine arabinoside: pharmacokinetics following different routes of administration (1982) (0)
- Prognostic Factors in Philadelphia+/BCR-ABL+ Acute Lymphoblastic Leukemia (2001) (0)
- Unusual myeloid leukaemia in patient with Hodgkin's disease. (1987) (0)
- ‘ ‘ focus on . . . ’ ’ session : profiling and prognosis (2008) (0)
- evaluation ofa novelpredominantly lymphocyte selective agentinlymphoid malignancies (1993) (0)
- Total Histology Nodular sclerosis Lymphocyte predominant Mixed cellularity Lymphocyte deplete Unspecified Stage II Ill IV B symptoms Outcome Complete remission Complete remission (0)
- Lowfield strength magnetic resonanceimaging ofbonemarrowin patients withmalignant lymphoma (1988) (0)
- Fludarabine in Low-Grade Lymphoma: st. Bartholomew's Hospital Experience (1997) (0)
- Wilm’s Tumour 1 (WT1) Mutations Are Associated with FLT3-ITD Mutation and Poor Prognosis in Normal Karyotype AML. (2006) (0)
- Follow-Up Results of a Prospective, Multicenter, Open-Label Study of Oral Fludarabine Phosphate in Patients with Previously Untreated B-CLL. (2005) (0)
- The treatment of low grade non-Hodgkin's lymphoma in elderly people. (1993) (0)
- Cotswolds Modification of the Ann Arbor Staging System for Hodgkin's Disease (1990) (0)
- More about: B-cell non-Hodgkin's lymphoma: evidence for the t(14;18) translocation in all hematopoietic cell lineages. (1999) (0)
- Gonadal Function in Hodgkin’s Disease: Long-Term Follow-Up of Chemotherapy (1983) (0)
- Chronic Lymphocytic Leukemia: Diagnosis and Management (2002) (0)
- Serum selenium in lymphoma - In reply (2004) (0)
- Diagnosis and Management (2020) (0)
- Letters to the editor (0)
- Presenting features of lymphoid neoplasms (2010) (0)
- Short Term Chemotherapy for Acute Myelogenous Leukaemia (1984) (0)
- Phase I Trial of the 131I-Labelled Anti-CD25 Antibody Basiliximab in the Treatment of Patients with Relapsed or Refractory Lymphoma. (2007) (0)
- Report o f a n I nternational W orkshop t o S tandardize Response C riteria f or N on-Hodgkin's L ymphomas (1999) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With T. Andrew Lister?
T. Andrew Lister is affiliated with the following schools: